A new study published in JAMA Network Open explores how cannabis legalization, both medical and recreational, is affecting the prescription of mental health medications in the U.S. The findings reveal a complex relationship, with cannabis laws leading to both decreased benzodiazepine prescriptions and increased use of antidepressants and antipsychotics. This underscores the need for further research into the broader impact of cannabis legalization on mental health treatment.
Nebraska voters will decide on the legalization of medical cannabis in November 2024 after two ballot measures were certified by the Secretary of State, despite legal challenges and allegations of signature fraud. The path to certification has been contentious, with lawsuits and criminal charges against a signature gatherer, but advocates remain optimistic.
A new study suggests the Czech Republic could be leaving millions of euros on the table by delaying the legalization of cannabis. Researchers have calculated that a fully regulated market could generate significant economic benefits, surpassing the current prohibitionist approach.
Leafly, a leading cannabis information platform, has announced a partnership with the New York Cannabis Retail Association (NYCRA) to support the state’s legal cannabis market. The partnership aims to create a more sustainable, equitable, and inclusive industry by sponsoring events, implementing marketing initiatives, and advocating for fair competition.
In a major victory for the Italian hemp industry, a court has temporarily suspended a decree that would have classified CBD as a narcotic. This decision comes as the Italian government has been pushing to ban all forms of cannabis flowers, including hemp, despite widespread protests and arguments that it would damage the industry and violate EU law. The future of the hemp sector remains uncertain, but this court ruling provides a glimmer of hope and highlights the ongoing legal battle over cannabis regulation in Italy.
Himachal Pradesh is set to legalize cannabis cultivation for scientific, industrial, and medicinal purposes. The state assembly has approved a report advocating for controlled cannabis cultivation, aiming to generate revenue and address financial challenges. The move comes after a committee studied the matter and recommended amending state NDPS rules.
Ohio’s adult-use cannabis market is experiencing a surge in sales, with dispensaries reporting strong demand since legalization. However, the economic boom has also raised concerns about road safety, prompting lawmakers to consider new testing measures. While research suggests a potential disconnect between THC levels and driving impairment, the debate over safety measures continues.
Former President Donald Trump’s recent support for cannabis legalization in Florida has sent ripples through the cannabis market, causing a mixed reaction among cannabis stocks. While some companies saw gains, reflecting optimism about potential federal changes, others experienced significant drops. This comes as Florida prepares for a November vote on a recreational cannabis initiative, which could significantly impact the industry.
Former President Donald Trump has surprisingly endorsed Florida’s recreational marijuana legalization initiative, but with stipulations for a controlled and safe program. He praised medical marijuana’s benefits and emphasized the need for a regulated system to avoid issues like those in New York, where he criticizes the current program. Trump’s endorsement comes with conditions such as age restrictions, public smoking bans, and a strong regulatory framework.
Former President Donald Trump has voiced his support for Florida’s marijuana legalization initiative on the November ballot, advocating for an end to criminalization and highlighting the economic and social benefits of cannabis legalization. His statement comes amidst growing national support for cannabis reform and the recognition of its potential to address various societal challenges.
